About Us
DELFI Diagnostics, Inc. (DELFI Diagnostics) is developing next-generation, blood-based tests that are reliable, accessible and deliver a new way to help detect cancer. Employing advanced machine-learning methods to whole-genome sequencing data, the DELFI ("DNA EvaLuation of Fragments for early Interception") platform is built to address the highest-burden health challenges. DELFI Diagnostics prioritizes solutions that have the potential to save lives on a global scale, including for historically underserved populations. DELFI Diagnostics’ platform relies on fragmentomics – the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments. FirstLook Lung, for individuals eligible for lung cancer screening, is DELFI Diagnostics’ first laboratory-developed screening test and can be part of routine blood work. FirstLook Lung uses millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early stage disease with a negative predictive value of 99.7 percent. This test has not been cleared or approved by the FDA.
In our passionate pursuit to radically improve health outcomes, we serve humanity when we:
Lead with Science, Anchor in Pragmatism: We pioneer life-changing science by ensuring quality, transparency, and rigor at all times. We explore thoughtfully, experiment smartly, and deliver impact with conviction.
Build With & For All: We embrace diverse backgrounds to innovate and achieve together. We are not just building a product - we aim to disrupt the path of cancer for all - no matter geography or socioeconomic class
Put We over I: We are a home for high-performing people. Through teamwork, we build collective intelligence. Each of us wins when those we serve and those who serve with us--win. We show up with empathy, humility, and integrity at every step of the journey.
In this role, you will be responsible for performing high complexity laboratory testing for cancer detection via next generation sequencing. You will work closely with automation, assay development and technology transfer scientists to build scalable infrastructure within the Clinical Laboratory.
*This position is a contract role for Tuesday - Saturday regular working hours of around 9AM - 5PM with an expected contract length of 6 months*
An equal opportunity employer
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
Join DELFI Diagnostics, Inc. as a Clinical Laboratory Scientist in Palo Alto, CA, where you’ll be at the forefront of developing groundbreaking, blood-based tests designed to detect cancer early. With your active Clinical Laboratory Scientist (CLS) license from California, you’ll perform high-complexity laboratory testing using next generation sequencing methodologies. You’ll be working alongside an innovative team of automation and assay development specialists to create a scalable, impactful laboratory infrastructure. In this contract role, Tuesday through Saturday from 9 AM to 5 PM, you'll not only conduct laboratory tests and analyses but also troubleshoot any complexities that could affect test performance. As someone who thrives in a collaborative environment, you’ll communicate your findings to a diverse group of professionals, contributing to DELFI’s mission of improving global health outcomes, particularly for underserved populations. If you have a passion for cancer research and possess a Bachelor’s degree in Biomedical Laboratory Sciences or Clinical Science along with 2+ years of clinical laboratory experience, we would love to see how you can make a difference in the lives of many. This isn't just a job; it's an opportunity to be part of a team that values inclusivity, empathy, and integrity while pushing the boundaries of scientific discovery.
Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. The com...
1 jobsSubscribe to Rise newsletter